Results 11 to 20 of about 28,587 (260)
Pharmacology and therapeutics of bronchodilators [PDF]
Pharmacological Reviews, 2012 Bronchodilators are central in the treatment of of airways disorders. They are the mainstay of the current management of chronic obstructive pulmonary disease (COPD) and are critical in the symptomatic management of asthma, although controversies around ...
Matera MG +16 more
core +5 more sources
Bronchodilators: current and future
Clinics in chest medicine, 2014 Bronchodilators are central in the symptomatic treatment of chronic obstructive pulmonary disease (COPD), although there is often limited reversibility of airflow obstruction.
CAZZOLA, MARIO +5 more
core +7 more sources
Bronchodilators for bronchiolitis [PDF]
Cochrane Database of Systematic Reviews, 2006 Bronchiolitis is an acute, viral lower respiratory tract infection affecting infants and often treated with bronchodilators.To assess the effects of bronchodilators on clinical outcomes in infants with acute bronchiolitis.We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library 2010, Issue 1) which contains the ...
Anne M, Gadomski, Melissa B, Scribani
openaire +4 more sources
Pharmaceuticals, 2022 The co-administration of a long-acting β2-agonist (LABA), and a long-acting muscarinic antagonist (LAMA), has been shown to be beneficial in the management of non-communicable chronic respiratory diseases, such as asthma and chronic obstructive pulmonary
Elena Menchi +5 more
doaj +1 more source
Determination of the effectiveness of short-term nebulizer therapy in bronchiectasis
Infusion & Chemotherapy, 2022 BACKGROUND. While the incidence of bronchiectasis is increasing every year, the treatment of this category of patients today is a real challenge for practical medicine, as the only existing guideline contain only low and medium quality data. OBJECTIVE.
K.Yu. Gashynova +2 more
doaj +1 more source
Rationale and Clinical Use of Bronchodilators in Adults with Bronchiectasis
, 2022 Currently, there is much controversy surrounding the therapeutic approach to pulmonary function abnormalities in patients with bronchiectasis and, consequently, whether and when to use bronchodilators in these patients.
Martinez-Garcia M. A. +5 more
core +2 more sources
South African Family Practice, 2020 International and national guidelines on chronic obstructive pulmonary disease (COPD) emphasise bronchodilators as first-line therapy. However, in considering them the ‘foundation’ of treatment, attention has shifted from the fact that COPD is ...
Elvis M. Irusen, Thandeka Malange
doaj +1 more source
The future of bronchodilation: looking for new classes of bronchodilators [PDF]
European Respiratory Review, 2019 Available bronchodilators can satisfy many of the needs of patients suffering from airway disorders, but they often do not relieve symptoms and their long-term use raises safety concerns. Therefore, there is interest in developing new classes that could help to overcome the limits that characterise the existing classes.At least nine potential new ...
Cazzola, Mario +2 more
openaire +5 more sources
Journal of the Formosan Medical Association, 2011 Microsomal epoxide hydrolase (EPHX) is an important enzyme that metabolizes harmful reactive epoxides from smoking. Genetic variations of this enzyme are thought to increase the risk of developing chronic obstructive pulmonary disease (COPD).
Chiung-Zuei Chen +5 more
doaj +1 more source
Long-acting Bronchodilators in COPD Management: One or Two?
, 2023 The management of chronic obstructive pulmonary disease (COPD) has changed significantly in this century, the most important element being the introduction of long-acting bronchodilators (LABD) as the basis of the treatment of patients with symptomatic ...
Konstantinos Kostikas +2 more
core +1 more source